Tag Archives: AKAM

Top Medical Stocks To Buy Right Now

Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry

Merck’s Keytruda Achieves Success In Phase 3 Study As A Combo Therapy

News: On Tuesday, Merck (MRK) announced positive results in a phase 3 study, using a combination of Keytruda and Alimta, treating patients with previously untreated non-small cell lung cancer (NSCLC). Alimta is a lung cancer drug developed by Eli Lilly (LLY). The phase 3 study, named Keynote-189, met on both endpoints of the study. The combo improved progression-free survival and overall-survival in patients.

Analysis: This news is really good for Merck. Not only did it report positive results for this indication, but it did so very early. That’s because this was just an interim look at the data. The final data for this trial was not expected until early 2019. The news might get even better, because this was just top-line results that were reported. The full set of detailed data from this study won’t be revealed until an upcoming medical conference. That means that investors have a lot to look forward too. This also trumps the notion that a Keytruda- chemo combo won’t work for first-line lung cancer. That’s because Merck pulled its European application last year for a Keytruda-chemo combo, because of results from a small phase 2 study. At that time, everyone was placing bets that the phase 3 study would also not show impressive data. Well, as you can see Merck has proved everyone wrong, and now it has a lot to hang its hat on. This win for Merck is bad for both Roche (OTCQX:RHHBY) and Bristol-Myers Squibb (BMY) which is why both traded lower as soon as the Merck results were announced.

Top Medical Stocks To Buy Right Now: First Choice Healthcare Solutions, Inc. (FCHS)

Advisors’ Opinion:

  • [By Logan Wallace]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare First Choice Healthcare Solutions to related businesses based on the strength of its risk, valuation, profitability, earnings, analyst recommendations, dividends and institutional ownership.

  • [By Logan Wallace]

    Telsey Advisory Group assumed coverage on shares of First Choice Healthcare Solutions (OTCMKTS:FCHS). Telsey Advisory Group issued a buy rating on the stock.

  • [By Logan Wallace]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare First Choice Healthcare Solutions to related businesses based on the strength of its risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations.

Top Medical Stocks To Buy Right Now: American States Water Company(AWR)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    There’s no guesswork involved, and the best part is – it’ll only take you 10 minutes per day! Click here now to start this once-in-a-lifetime journey…

    Stocks to Watch Today: KHC, HD, JWN, M, AAPL
    Kraft Heinz Co. (NYSE: KHC) is still licking its wounds after an abysmal earnings report on Thursday and a weak 2019 outlook. The consumer goods giant is looking to reshape its business as consumer tastes continue to evolve. According to reports, the firm – backed heavily by Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.A) – is considering a deal to sell its Maxwell House brand. Warren Buffett is also affecting shares of Apple Inc. (NASDAQ: AAPL). Although AAPL stock added 0.4% in pre-market hours, Buffett said he would not purchase more shares of the company stock at these levels. However, should AAPL stock pull back in the near future, the “Oracle of Omaha” would consider purchasing more. Earnings season may be winding down, but concerns about the U.S. brick-and-mortar retail industry are always high. This week, Home Depot Inc. (NYSE: HD), Nordstrom Inc. (NYSE: JWN), and Macy’s Inc. (NYSE: M) will report earnings from the holiday quarter. Look for earnings reports from American States Water Co. (NYSE: AWR), Chatham Lodging Trust (NYSE: CLDT), EPR Properties (NYSE: EPR), Etsy Inc. (NASDAQ: ETSY), Life Storage Inc. (NYSE: LSI), Mosaic Co. (NYSE: MOS), Oneok Inc. (NYSE: OKE), Potbelly Corp. (NASDAQ: PBPB), Preferred Apartment Communities Inc. (NYSE: APTS), Rent-A-Center Inc. (NASDAQ: RCII), Shake Shack Inc. (NYSE: SHAK), and Tenet Healthcare Corp. (NYSE: THC).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Neha Chamaria]

    In terms of dividend growth, only four of the above stocks — 3M, Colgate-Palmolive, Coca-Cola, and Procter & Gamble — feature among the 10 fastest dividend-growth kings. In other words, there are six other stocks from the dividend kings list that have grown their dividends at a faster pace than most stocks in the above table in the past decade, some even at double-digits.  

    Six top dividend kings by dividend growth

    Dividend King 10-Year Dividend CAGR Current Dividend Yield Payout Ratio (TTM)
    Lowe’s Companies  18.5% 2% 34.5%
    Hormel Foods  16.3% 2.1% 39.2%
    Parker-Hannifin Corp (NYSE:PH) 14% 1.7% 35.2%
    Nordson Corporation  12.2% 0.9% 13.3%
    Dover Corp (NYSE:DOV) 9% 2% 37.4%
    American States Water (NYSE:AWR) 7.6% 1.9% 54.8%

    TTM: Trailing 12 months. Data sources: YCharts and Yahoo! Finance. Table by author.

  • [By Neha Chamaria and Jason Hall]

    Two such amazing but little-known dividend-paying companies that our Motley Fool contributors have identified are American States Water (NYSE:AWR) and Caretrust REIT Inc. (NASDAQ:CTRE). Read along to know why you should have these stocks on your radar.

  • [By Motley Fool Transcribing]

    American States Water (NYSE:AWR) Q4 2018 Earnings Conference CallFeb. 26, 2019 2:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Medical Stocks To Buy Right Now: AdvanSix Inc. (ASIX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Algert Global LLC trimmed its position in shares of AdvanSix Inc (NYSE:ASIX) by 58.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,001 shares of the company’s stock after selling 29,859 shares during the period. Algert Global LLC owned about 0.07% of AdvanSix worth $511,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    AdvanSix (NYSE:ASIX) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday.

  • [By Max Byerly]

    AdvanSix (NYSE:ASIX) Director Michael Marberry bought 1,398 shares of the stock in a transaction on Monday, May 7th. The stock was purchased at an average price of $35.74 per share, for a total transaction of $49,964.52. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

  • [By Ethan Ryder]

    GSA Capital Partners LLP reduced its holdings in AdvanSix Inc (NYSE:ASIX) by 36.7% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 24,620 shares of the company’s stock after selling 14,277 shares during the quarter. GSA Capital Partners LLP owned about 0.08% of AdvanSix worth $856,000 as of its most recent filing with the SEC.

Top Medical Stocks To Buy Right Now: Akamai Technologies, Inc.(AKAM)

Advisors’ Opinion:

  • [By Anders Bylund]

    During the first quarter, Limelight settled the last of its legal battles with rival Akamai Technologies (NASDAQ:AKAM). The terms of this settlement were not publicly addressed, but Limelight was the plaintiff and Akamai the defendant in the last patent infringement case, though Akamai also returned fire with several counterclaims. If the settlement had any financial effects, we’ll see those on Akamai’s and Limelight’s financial statements over time. If not, the two companies just removed a source of financial uncertainty.

  • [By ]

    There could be a for sale sign planted in the ground at tech pioneer Akamai (AKAM) .

    “We’re a public company and our board, which is very professional and diligent, is always going to do the right thing for shareholders,” Akamai CEO Tom Leighton told TheStreet when asked if the company he co-founded in 1998 was for sale. While Leighton left the door open on a possible sale, he added that Akamai has strong prospects as a stand-alone company as well.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Akamai Technologies (AKAM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Akamai Technologies, Inc. (NASDAQ:AKAM)’s share price reached a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $81.46 and last traded at $81.47, with a volume of 38096 shares traded. The stock had previously closed at $81.23.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Akamai Technologies, Inc. (NASDAQ: AKAM) which rose about 7% to $74.89. The stock’s 52-week range is $44.65 to $75.00. Volume was roughly 4 million compared to the daily average volume of 2.3 million.

  • [By Garrett Baldwin]

    Click here to learn more.

    Stocks to Watch Today: GILD, AMZN, UAA, JPM, AAPL, NFLX
    Shares of Gilead Sciences Inc. (NASDAQ: GILD) fell 2.4% after the biotech giant announced disappointing results from a trial for a drug for chronic liver disease. In deal news, Amazon.com Inc. (NASDAQ: AMZN) will buy Wi-Fi/home router startup Eero for an undisclosed amount. The global e-commerce giant has been going on a smart-home acquisition streak. Last year, the firm bought video doorbell maker Ring for $1 billion. Eero is based in San Francisco and was founded in 2014. The firm makes mesh routers that aim to eliminate dead zones across a house or business location. Shares of Under Armour Inc. (NYSE: UAA) gained more than 2.2% after the company reported earnings before the bell. The sports apparel giant reported earnings per share of $0.09 (on an adjusted basis). That figure beat expectations of $0.04. The company’s sales were off about 6% in the fourth quarter but cited a big jump in foreign revenue. Last week, JPMorgan Chase & Co. (NYSE: JPM) released a report that recommended one of the deals of the decade. The bank has called for Apple Inc. (NASDAQ: AAPL) to buy streaming giant Netflix Inc. (NASDAQ: NFLX). This deal is a no-brainer in today’s market. We break down what a deal would look like, how it benefits both sides, and how it would be like rocket fuel for Apple stock. Here’s what you need to know. Look for earnings reports from Activision Blizzard Inc. (NASDAQ: ATVI), Aircastle Ltd. (NYSE: AYR), Akamai Technologies Inc. (NASDAQ: AKAM), Ares Capital Corp. (NASDAQ: ARCC), Denny’s Corp. (NASDAQ: DENN), Groupon Inc. (NASDAQ: GRPN), HubSpot Inc. (NASDAQ: HUBS), Molson Coors Brewing Co. (NYSE: TAP), Occidental Petroleum Corp. (NYSE: OXY), Shopify Inc. (NASDAQ: SHOP), and TripAdvisor Inc. (NASDAQ: TRIP).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

Top Medical Stocks To Buy Right Now: United Technologies Corporation(UTX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:

    Get United Technologies alerts:

    United Technologies Co. (UTX) Receives Consensus Rating of “Buy” from Brokerages (americanbankingnews.com) United Technologies (UTX) & TAT Technologies (TATT) Head to Head Comparison (americanbankingnews.com) United Technologies to Sell Ice Cream-Machine Manufacturer for $1 Billion (wsj.com) United Technologies Sells Ice-Cream Machine Unit for $1 Billion (finance.yahoo.com) [$$] United Technologies to Sell Ice Cream-Machine Manufacturer for $1 Billion (finance.yahoo.com)

    A number of research firms have recently commented on UTX. ValuEngine upgraded United Technologies from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Cowen reiterated a “hold” rating and issued a $141.00 price objective on shares of United Technologies in a research note on Thursday, January 25th. Stifel Nicolaus reiterated a “hold” rating and issued a $146.00 price objective (up from $124.00) on shares of United Technologies in a research note on Thursday, January 25th. Sanford C. Bernstein reiterated a “positive” rating and issued a $153.00 price objective (up from $135.00) on shares of United Technologies in a research note on Tuesday, January 30th. Finally, Zacks Investment Research lowered United Technologies from a “buy” rating to a “hold” rating in a research note on Monday, January 22nd. Nine equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $138.21.

  • [By Paul Ausick]

    United Technologies Corp. (NYSE: UTX) traded down 1.65% at $134.32. The stock’s 52-week range is $106.85 to $137.39. Volume was about 15% above the daily average of around 3.1 million. The company had no specific news Tuesday.

  • [By Max Byerly]

    Daiwa Securities Group Inc. raised its holdings in shares of United Technologies Co. (NYSE:UTX) by 10.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 63,924 shares of the conglomerate’s stock after purchasing an additional 5,852 shares during the quarter. Daiwa Securities Group Inc.’s holdings in United Technologies were worth $8,042,000 as of its most recent SEC filing.

  • [By Paul Ausick]

    United Technologies Corp. (NYSE: UTX) traded up 1.50% at $130.92. The stock’s 52-week range is $109.10 to $139.24. Volume was about 15% below the daily average of around 3.9 million shares.

  • [By Lee Samaha]

    First, commercial aviation markets have been stronger than most people expected coming into 2018. Strong aerospace markets are behind Honeywell International and United Technologies (NYSE:UTX)  beating earnings expectations in 2018, and as you can see below that GE Aviation aftermarket sales continued to grow at a near 20% rate in the first half.

  • [By Sean Williams]

    Below is a list of all 30 current Dow components ranked, according to the date they were added, or most recently added (assuming they’ve bounced in and out of the index like GE), to the index.

    ExxonMobil (NYSE:XOM): Added Oct. 1, 1928 Procter & Gamble (NYSE:PG): Added May 26, 1932 DowDuPont (NYSE:DWDP): Added Nov. 20, 1935 United Technologies (NYSE:UTX): Added March 4, 1939 3M: Added Aug. 9, 1976 IBM: Added June 29, 1979 Merck: Added Jun. 29, 1979 American Express: Added Aug. 30, 1982 McDonald’s: Added Oct. 30, 1985 Boeing: Added March 12, 1987 Coca-Cola: Added March 12, 1987 Caterpillar: Added May 6, 1991 JPMorgan Chase: Added May 6, 1991 Walt Disney: Added May 6, 1991 Johnson & Johnson: Added March 17, 1997 Walmart: Added March 17, 1997 Home Depot: Added Nov. 1, 1999 Intel: Added Nov. 1, 1999 Microsoft: Added Nov. 1, 1999 Pfizer: Added April 8, 2004 Verizon: Added April 8, 2004 Chevron: Added Feb. 19, 2008 Cisco Systems: Added June 8, 2009 Travelers Cos.: Added June 8, 2009 UnitedHealth Group: Added Sept. 24, 2012 Goldman Sachs: Added Sept. 23, 2013 Nike: Added Sept. 23, 2013 Visa: Added Sept. 23, 2013 Apple: Added March 19, 2015 Walgreens Boots Alliance: Added Jun. 26, 2018

    As you’ll note, a third of the components have only been part of the Dow for the past 14 years. Just four components — ExxonMobil, Procter & Gamble, DowDuPont, and United Technologies — have been included for more than 42 consecutive years.

Top Medical Stocks To Buy Right Now: Cohen & Steers Select Preferred and Income Fund, Inc.(PSF)

Advisors’ Opinion:

  • [By Max Byerly]

    Media stories about Cohen & Steers Select Pref & Inc Fd (NYSE:PSF) have trended positive recently, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cohen & Steers Select Pref & Inc Fd earned a media sentiment score of 0.39 on Accern’s scale. Accern also gave headlines about the company an impact score of 48.661768322942 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Top 5 Safest Stocks To Invest In Right Now

&l;img class=&q;dam-image getty size-large wp-image-1125913011&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1125913011/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g;

It&s;s awfully tempting. You see that money in your 401(k) plan account just sitting there. And you think of all the possible uses for it. Why not take a loan? You will pay it back — with interest!

Generally, that is a really bad idea. Here are the reasons why.

&l;strong&g;You will likely forfeit some company matching contributions&l;/strong&g;

Many individuals who borrow from their 401(k) accounts end up stopping or lowering their contributions while they are paying back their loans. This often results in the loss of 401(k) matching contributions when their contribution rates fall below the maximum matched percentage.

There is no better investment you can make than receiving free money in the form of company matching contributions. It is the safest, easiest way to earn 25%, 50% or 100% — depending upon your company&s;s matching percentage.

Top 5 Safest Stocks To Invest In Right Now: Akamai Technologies, Inc.(AKAM)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Click here to learn more.

    Stocks to Watch Today: GILD, AMZN, UAA, JPM, AAPL, NFLX
    Shares of Gilead Sciences Inc. (NASDAQ: GILD) fell 2.4% after the biotech giant announced disappointing results from a trial for a drug for chronic liver disease. In deal news, Amazon.com Inc. (NASDAQ: AMZN) will buy Wi-Fi/home router startup Eero for an undisclosed amount. The global e-commerce giant has been going on a smart-home acquisition streak. Last year, the firm bought video doorbell maker Ring for $1 billion. Eero is based in San Francisco and was founded in 2014. The firm makes mesh routers that aim to eliminate dead zones across a house or business location. Shares of Under Armour Inc. (NYSE: UAA) gained more than 2.2% after the company reported earnings before the bell. The sports apparel giant reported earnings per share of $0.09 (on an adjusted basis). That figure beat expectations of $0.04. The company’s sales were off about 6% in the fourth quarter but cited a big jump in foreign revenue. Last week, JPMorgan Chase & Co. (NYSE: JPM) released a report that recommended one of the deals of the decade. The bank has called for Apple Inc. (NASDAQ: AAPL) to buy streaming giant Netflix Inc. (NASDAQ: NFLX). This deal is a no-brainer in today’s market. We break down what a deal would look like, how it benefits both sides, and how it would be like rocket fuel for Apple stock. Here’s what you need to know. Look for earnings reports from Activision Blizzard Inc. (NASDAQ: ATVI), Aircastle Ltd. (NYSE: AYR), Akamai Technologies Inc. (NASDAQ: AKAM), Ares Capital Corp. (NASDAQ: ARCC), Denny’s Corp. (NASDAQ: DENN), Groupon Inc. (NASDAQ: GRPN), HubSpot Inc. (NASDAQ: HUBS), Molson Coors Brewing Co. (NYSE: TAP), Occidental Petroleum Corp. (NYSE: OXY), Shopify Inc. (NASDAQ: SHOP), and TripAdvisor Inc. (NASDAQ: TRIP).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By ]

    There could be a for sale sign planted in the ground at tech pioneer Akamai (AKAM) .

    “We’re a public company and our board, which is very professional and diligent, is always going to do the right thing for shareholders,” Akamai CEO Tom Leighton told TheStreet when asked if the company he co-founded in 1998 was for sale. While Leighton left the door open on a possible sale, he added that Akamai has strong prospects as a stand-alone company as well.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Akamai Technologies (AKAM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Meanwhile, Akamai’s (AKAM) CEO Tom Leighton didn’t shut the door to a potential sale of the company in an interview with me. Recent speculation on Wall Street is that Akamai would be an ideal fit for IBM (IBM) . 

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Akamai Technologies (AKAM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Safest Stocks To Invest In Right Now: Dynavax Technologies Corporation(DVAX)

Advisors’ Opinion:

  • [By George Budwell]

    Shares of Dynavax Technologies (NASDAQ:DVAX), a vaccine and immuno-oncology specialist, dropped by 15.9% last month, according to data from S&P Global Market Intelligence. What sparked this sell-off?

  • [By Motley Fool Transcription]

    Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2018 Earnings Conference Call February 26, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get Dynavax Technologies alerts:

    Dynavax Technologies Co. (DVAX) Receives Average Recommendation of “Buy” from Brokerages (americanbankingnews.com) Earnings per share (EPS) in the Spotlight – Dynavax Technologies Corporation (NASDAQ: DVAX) (stocksmarketcap.com) Is the Stock Safe to Invest? – Dynavax Technologies Corporation (NASDAQ:DVAX) (nasdaqjournal.com) Investor’s Watch List: Dynavax Technologies Corporation (DVAX) (nasdaqplace.com) You Need to Watch this stock? Dynavax Technologies Corporation (DVAX) (connectinginvestor.com)

    DVAX has been the topic of several analyst reports. Cantor Fitzgerald set a $27.00 price objective on Dynavax Technologies and gave the company a “buy” rating in a research note on Wednesday, May 16th. ValuEngine lowered Dynavax Technologies from a “hold” rating to a “sell” rating in a research note on Tuesday, May 1st. BidaskClub downgraded Dynavax Technologies from a “buy” rating to a “hold” rating in a report on Sunday, April 22nd. Finally, JPMorgan Chase & Co. raised Dynavax Technologies from a “neutral” rating to an “overweight” rating and set a $25.00 target price on the stock in a report on Thursday, May 10th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating to the stock. Dynavax Technologies currently has a consensus rating of “Buy” and an average target price of $24.67.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Dynavax Technologies (DVAX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights]

    For Dynavax Technologies Corporation (NASDAQ:DVAX), this old adage was spot-on. Between Jan. 1 and Nov. 8, 2017, the biotech stock increased more than fivefold. Investors eagerly awaited FDA approval of Dynavax’s Heplisav-B hepatitis B vaccine. After two unsuccessful attempts at approval, Heplisav-B finally won a green light from the FDA on Nov. 9. Since then, Dynavax’s share price has dropped 37%. 

Top 5 Safest Stocks To Invest In Right Now: Thor Industries Inc.(THO)

Advisors’ Opinion:

  • [By Keith Noonan, Rich Smith, and Tyler Crowe]

    For this roundtable, we asked three Motley Fool contributors to profile a company that has the makings of a long-term winner. Read on to see why they think that Thor Industries (NYSE:THO), Waste Management (NYSE:WM), and Activision Blizzard (NASDAQ:ATVI) are stocks that are poised to do big things over the next 20 years.

  • [By Asit Sharma]

    Leading recreational vehicle (RV) manufacturer Thor Industries, Inc. (NYSE:THO) reported a drop in revenue, as well as deterioration in several key financial metrics, in its fiscal fourth-quarter 2018 earnings report issued Thursday before the markets opened. The unexpectedly tepid performance jarred Thor shares, which traded down nearly 15% early in the trading session following the earnings release. Let’s review headline numbers below and uncover why shareholders found the report distasteful:

  • [By Ethan Ryder]

    Tahoe Resources (TSE:THO) (NASDAQ:TAHO) was downgraded by analysts at Beacon Securities from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday. They currently have a C$5.75 price target on the stock, down from their prior price target of C$10.00. Beacon Securities’ price objective would indicate a potential upside of 61.52% from the company’s current price.

  • [By Logan Wallace]

    Tahoe Resources (TSE:THO) (NASDAQ:TAHO) – Equities research analysts at National Bank Financial reduced their FY2018 earnings estimates for shares of Tahoe Resources in a research report issued on Monday, April 9th. National Bank Financial analyst M. Parkin now forecasts that the company will earn $0.29 per share for the year, down from their prior forecast of $0.35. National Bank Financial currently has a “Sector Perform” rating and a $8.00 price objective on the stock.

  • [By Ethan Ryder]

    First Allied Advisory Services Inc. lowered its position in Thor Industries, Inc. (NYSE:THO) by 20.5% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 4,104 shares of the construction company’s stock after selling 1,060 shares during the period. First Allied Advisory Services Inc.’s holdings in Thor Industries were worth $401,000 at the end of the most recent quarter.

Top 5 Safest Stocks To Invest In Right Now: American River Bankshares(AMRB)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on American River Bankshares (AMRB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on American River Bankshares (AMRB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    American River Bankshares (NASDAQ:AMRB) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday.

Top 5 Safest Stocks To Invest In Right Now: Curis, Inc.(CRIS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) rose 65.5 percent to $179.50 in pre-market trading. Madrigal Pharma disclosed that MGL-3196 achieved liver biopsy endpoints in patients with NASH at 36 weeks in Phase 2 trial.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 34.8 percent to $6.70 in pre-market trading after falling 4.42 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares rose 31.5 percent to $2.19 in pre-market trading after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Curis, Inc. (NASDAQ: CRIS) shares rose 27.2 percent to $2.90 in pre-market trading after the company reported FDA Fast Track designation for CUDC-907 development in patients with relapse, refractory diffuse large B-cell lymphoma.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 16.7 percent to $2.51 in pre-market trading.
    Tilly's, Inc. (NYSE: TLYS) rose 14.7 percent to $14.00 in pre-market trading as the company reported better-than-expected earnings for its first quarter and issued a strong Q2 outlook.
    Express, Inc. (NYSE: EXPR) rose 14.3 percent to $10.49 in pre-market trading after the company reported better-than-expected results for its first quarter.
    NGL Energy Partners LP (NYSE: NGL) rose 12.8 percent to $12.10 in pre-market trading after reporting Q4 earnings beat.
    J.Jill, Inc. (NYSE: JILL) rose 11.3 percent to $6.90 in pre-market trading after the company posted upbeat quarterly earnings.
    TapImmune, Inc. (NASDAQ: TPIV) shares rose 10 percent to $5.60 in pre-market trading after climbing 24.15 percent on Wednesday.
    Frontline Ltd. (NYSE: FRO) rose 9.8 percent to $5.74 in pre-market trading after Q1 results beat estimates.
    Tech Data Corporation (NASDAQ: TECD) rose 8.8 percent to $89.65 in pre-market trading following better-than-expected Q1 earnings.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 7.1 percent to $3.65 in pre-market tra
  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday.
    Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program.
    J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings.
    Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday.
    TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results.
    CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210.
    The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Keysight Technologies, Inc. (NYSE: KEY
  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Brian Feroldi]

    Curis, Inc. (NASDAQ:CRIS), a beaten up clinical-stage biopharma focused on cancer, jumped 23% as of 2:43 p.m. EDT on Thursday in response to announcing that one of its key compounds has received Food and Drug Administration (FDA) Fast Track designation.

  • [By Joseph Griffin]

    Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

    Get Curis alerts:

    $2.41 Million in Sales Expected for Curis, Inc. (CRIS) This Quarter (americanbankingnews.com) Curis Stock Scheduled to Reverse Split on Wednesday, May 30th (CRIS) (americanbankingnews.com) Zacks: Analysts Expect Curis, Inc. (CRIS) to Post -$0.09 Earnings Per Share (americanbankingnews.com) Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development (finance.yahoo.com) Is Curis, Inc. (CRIS) In Search of Footing? (nmsunews.com)

    Shares of Curis stock traded up $0.01 on Monday, hitting $0.45. The company had a trading volume of 1,290,968 shares, compared to its average volume of 1,462,753. The stock has a market capitalization of $74.57 million, a PE ratio of -1.25 and a beta of 1.29. Curis has a twelve month low of $0.41 and a twelve month high of $2.27. The company has a quick ratio of 3.60, a current ratio of 3.60 and a debt-to-equity ratio of 2.24.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 18.2 percent to $4.55 in pre-market trading after the company declared a $0.70 per share special dividend.
    Co-Diagnostics, Inc. (NASDAQ: CODX) rose 11.7 percent to $3.24 in pre-market trading after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Abercrombie & Fitch Co. (NYSE: ANF) shares rose 8.6 percent to $25.95 in pre-market trading after the company posted upbeat Q1 results.
    Zuora, Inc. (NYSE: ZUO) shares rose 8 percent to $23.95 in pre-market trading after the company reported upbeat Q1 earnings and issued strong outlook.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares rose 7.8 percent to $113.25 in pre-market trading after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    OPKO Health, Inc. (NYSE: OPK) rose 5.7 percent to $4.10 in pre-market trading.
    Lannett Company, Inc. (NYSE: LCI) rose 5.5 percent to $17.45 in pre-market trading following the FDA approval for Levofloxacin Oral Solution.
    Eversource Energy (NYSE: ES) shares rose 5 percent to $59.8 in pre-market trading.
    VMware, Inc. (NYSE: VMW) rose 4.6 percent to $143.74 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Thursday.
    Energy Transfer Partners, L.P. (NYSE: ETP) rose 4.3 percent to $19.80 in pre-market trading after the company reported the Federal Energy Regulatory Commission approval to place Rover pipeline’s full Mainline B into service.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 4.3 percent to $7.73 in pre-market trading after declining 4.26 percent on Thursday.
    Curis, Inc. (NASDAQ: CRIS) rose 4.3 percent to $2.90 in pre-market trading after jumping 21.93 percent on Thursday.
    Sasol Limited (NYSE: SSL) rose 4.2 percent to $37.91 in pre-market trading.
    Nucor Corporatio

Top 10 Heal Care Stocks To Own Right Now

Some might think investors in their 60s should steer clear of stocks. And that’s not entirely correct.

Sure, shifting some of your portfolio to less volatile investing alternatives like bonds makes sense. However, stocks should still be an important component of investment accounts for individuals in this age group. The big question, though, is: Which stocks to buy?

I think Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL), Iron Mountain (NYSE:IRM), and Pfizer (NYSE:PFE) are great picks for investors in their 60s. Here’s what makes these three stocks stand out.

Alphabet
You might be surprised for Google parent Alphabet to make the list since the stock doesn’t pay a dividend. But while it’s great to have solid dividend stocks in your portfolio (and we’ll get to two of them shortly), stocks of companies with strong moats and excellent growth prospects should be included as well. Alphabet checks off both of those boxes in a big way.

Top 10 Heal Care Stocks To Own Right Now: Akamai Technologies, Inc.(AKAM)

Advisors’ Opinion:

  • [By ]

    Meanwhile, Akamai’s (AKAM) CEO Tom Leighton didn’t shut the door to a potential sale of the company in an interview with me. Recent speculation on Wall Street is that Akamai would be an ideal fit for IBM (IBM) . 

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Akamai Technologies, Inc. (NASDAQ: AKAM) which rose about 7% to $74.89. The stocks 52-week range is $44.65 to $75.00. Volume was roughly 4 million compared to the daily average volume of 2.3 million.

  • [By ]

    There could be a for sale sign planted in the ground at tech pioneer Akamai (AKAM) .

    “We’re a public company and our board, which is very professional and diligent, is always going to do the right thing for shareholders,” Akamai CEO Tom Leighton told TheStreet when asked if the company he co-founded in 1998 was for sale. While Leighton left the door open on a possible sale, he added that Akamai has strong prospects as a stand-alone company as well.

  • [By Joseph Griffin]

    Limelight Networks (NASDAQ: LLNW) and Akamai Technologies (NASDAQ:AKAM) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Top 10 Heal Care Stocks To Own Right Now: Retail Properties of America, Inc.(RPAI)

Advisors’ Opinion:

  • [By Lee Jackson]

    Retail Properties of America Inc. (NYSE: RPAI) investors receive a 5.7% yield. The stock was last seen trading at $11.45 a share. The 52-week range is $10.94 to $14.70, and the consensus price target is $15.44.

  • [By Shane Hupp]

    Press coverage about Retail Properties of America (NYSE:RPAI) has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Retail Properties of America earned a news impact score of 0.19 on Accern’s scale. Accern also assigned press coverage about the real estate investment trust an impact score of 48.1880076437209 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Retail Properties of America (RPAI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Own Right Now: Patriot Transportation Holding, Inc.(PATI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Patriot Transportation Holding Inc (NASDAQ:PATI) VP John D. Milton, Jr. sold 5,601 shares of the business’s stock in a transaction that occurred on Thursday, June 14th. The shares were sold at an average price of $22.51, for a total value of $126,078.51. Following the sale, the vice president now owns 402 shares in the company, valued at $9,049.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Top 10 Heal Care Stocks To Own Right Now: Eaton Vance Enhanced Equity Income Fund II(EOS)

Advisors’ Opinion:

  • [By Shane Hupp]

    EOS (CURRENCY:EOS) traded up 9.3% against the US dollar during the 1 day period ending at 20:00 PM E.T. on July 2nd. During the last week, EOS has traded up 8.5% against the US dollar. One EOS token can now be purchased for $8.89 or 0.00135160 BTC on exchanges including Zebpay, CoinEx Market, ChaoEX and Tidex. EOS has a market cap of $7.96 billion and $1.02 billion worth of EOS was traded on exchanges in the last day.

  • [By Stephan Byrd]

    EOS (CURRENCY:EOS) traded 4.1% higher against the US dollar during the 24 hour period ending at 14:00 PM E.T. on June 27th. EOS has a total market capitalization of $7.24 billion and $772.07 million worth of EOS was traded on exchanges in the last 24 hours. Over the last week, EOS has traded down 22.9% against the US dollar. One EOS token can currently be purchased for approximately $8.08 or 0.00131687 BTC on major cryptocurrency exchanges including Kuna, Bibox, Cryptopia and CoinExchange.

  • [By Joseph Griffin]

    EOS (CURRENCY:EOS) traded 0.7% higher against the U.S. dollar during the 1 day period ending at 16:00 PM ET on July 4th. In the last seven days, EOS has traded 13.1% higher against the U.S. dollar. One EOS token can now be purchased for approximately $9.05 or 0.00135304 BTC on major cryptocurrency exchanges including DragonEX, ChaoEX, Hotbit and HitBTC. EOS has a market cap of $8.11 billion and approximately $912.71 million worth of EOS was traded on exchanges in the last 24 hours.

Top 10 Heal Care Stocks To Own Right Now: TripAdvisor, Inc.(TRIP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Tripadvisor Inc Common Stock (NASDAQ: TRIP) and Match Group (NASDAQ:MTCH) are both retail/wholesale companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, earnings, institutional ownership and profitability.

  • [By Demitrios Kalogeropoulos]

    There are many reasons an investor might be attracted to TripAdvisor (NASDAQ:TRIP) stock. It boasts an enviable position in the online hotel booking space, after all, and the travel specialist is cultivating new business lines that might soon become significant revenue streams in their own rights.

  • [By Dan Caplinger]

    For a travel website to prosper, it should ideally see growing business in every aspect of travel. Between hotels, airfare, rental cars, and attractions, travelers spend a lot of money, and investors look to TripAdvisor (NASDAQ:TRIP) to claim its fair share of that growing pie. Yet in large part due to rising competitive pressures, TripAdvisor has had trouble finding the growth that shareholders expect, and much of what’s holding it back comes from a part of the travel business that you’d think would be doing better for the company.

  • [By Lisa Levin] Gainers
    Amedica Corporation (NASDAQ: AMDA) rose 31.3 percent to $4.11 in pre-market trading after climbing 181.98 percent on Tuesday.
    ZAGG Inc (NASDAQ: ZAGG) rose 18.7 percent to $13.65 in pre-market trading after the company posted better-than-expected Q1 earnings.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 18.6 percent to $46.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 15 percent to $2.08 in pre-market trading after reporting Q4 results.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 9.8 percent to $49.00 in pre-market trading following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 8.1 percent to $21.06 in pre-market trading following Q1 results.
    OPKO Health, Inc. (NASDAQ: OPK) shares rose 6.8 percent to $3.44 in pre-market trading following Q1 beat.
    Tel-Instrument Electronics Corp. (NYSE: TIK) rose 6.7 percent to $3.20 in pre-market trading after surging 25.37 percent on Tuesday.
    KBS Fashion Group Limited (NASDAQ: KBSF) rose 6.4 percent to $5.84 in pre-market trading after jumping 9.36 percent on Tuesday.
    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 6.6 percent to $8.26 in pre-market trading after reporting Q2 earnings.
    New Relic, Inc. (NYSE: NEWR) rose 6.3 percent to $82.00 in pre-market trading following Q4 results.
    Match Group, Inc. (NASDAQ: MTCH) rose 5.8 percent to $38.43 in pre-market trading after reporting upbeat Q1 earnings.
    Prestige Brands Holdings, Inc. (NYSE: PBH) rose 5.2 percent to $30.62 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Steve Symington]

    Shares ofTripAdvisor (NASDAQ:TRIP) were down 12.9% as of 2:50 p.m. EDT Thursday after the online travel site announced mixed second-quarter 2018 results. TripAdvisor’s quarterly revenue grew 2% year over year, to $433 million, and translated to adjusted net income of $58 million, or $0.41 per share, up from $0.38 per share in the same year-ago period.

Top 10 Heal Care Stocks To Own Right Now: Chuy's Holdings, Inc.(CHUY)

Advisors’ Opinion:

  • [By Logan Wallace]

    News headlines about Chuy’s (NASDAQ:CHUY) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Chuy’s earned a media sentiment score of 0.15 on Accern’s scale. Accern also gave headlines about the restaurant operator an impact score of 46.3414123476192 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Max Byerly]

    Chuy’s (NASDAQ:CHUY) CEO Steven J. Hislop sold 3,690 shares of the company’s stock in a transaction dated Friday, May 4th. The stock was sold at an average price of $30.00, for a total transaction of $110,700.00. Following the completion of the transaction, the chief executive officer now owns 132,460 shares in the company, valued at approximately $3,973,800. The sale was disclosed in a legal filing with the SEC, which is available through this link.

  • [By Joseph Griffin]

    Chuy’s (NASDAQ:CHUY) had its price target hoisted by BMO Capital Markets from $27.00 to $28.00 in a report published on Wednesday, Marketbeat.com reports. The firm currently has a hold rating on the restaurant operator’s stock.

  • [By Shane Hupp]

    Arcos Dorados (NYSE: ARCO) and Chuy’s (NASDAQ:CHUY) are both small-cap retail/wholesale companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

  • [By Motley Fool Staff]

    Chuy’s Holdings (NASDAQ:CHUY) Q1 2018 Earnings Conference CallMay. 8, 2018 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Dustin Parrett]

    Here are the top restaurant stocks we’ve found, with one-year price targets showing gains as high as 74%…

    Restaurant Stocks to Buy, No. 1: Chuy’s Holdings Inc. (Nasdaq: CHUY)

    Chuy’s Holdings Inc. (Nasdaq: CHUY) is a Texas-based chain of casual Tex-Mex restaurants.

Top 10 Heal Care Stocks To Own Right Now: Performant Financial Corporation(PFMT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
    VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
    Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
    Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
    Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
    Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
    Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
    Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
    Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
    Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
    Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent

  • [By Lisa Levin]

    Shares of Performant Financial Corporation (NASDAQ: PFMT) were down 29 percent to $2.20. Performant Financial is expected to release Q1 earnings on May 8.

  • [By Stephan Byrd]

    Performant Financial (NASDAQ: PFMT) and Donnelley Financial Solns (NYSE:DFIN) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

  • [By Ethan Ryder]

    SEA (NYSE: SE) and Performant Financial (NASDAQ:PFMT) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

Top 10 Heal Care Stocks To Own Right Now: LiqTech International, Inc.(LIQT)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Money Morning Staff Reports]

    But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we’ll show you a small-cap stock with great profit potential in its future…

    Penny Stock Current Share Price Law Month’s Gain
    Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85%
    Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40%
    Vivis Inc. (Nasdaq: VVUS) $0.77 150.41%
    Adomani Inc. (Nasdaq: ADOM) $1.49 137.68%
    NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88%
    Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06%
    Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12%
    ArQule Inc. (Nasdaq: ARQL) $4.88 90.74%
    LiqTech International Inc. (NYSE: LIQT) $0.66 85.60%
    Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

    While last month’s gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

  • [By Shane Hupp]

    LiqTech International Inc (NYSEAMERICAN:LIQT) saw a significant decline in short interest in the month of June. As of June 15th, there was short interest totalling 320,188 shares, a decline of 9.3% from the May 31st total of 352,974 shares. Currently, 0.6% of the company’s shares are short sold. Based on an average daily volume of 364,702 shares, the short-interest ratio is presently 0.9 days.

Top 10 Heal Care Stocks To Own Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors’ Opinion:

  • [By Logan Wallace]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Although Alnylam has a broad and promising pipeline, we note that most candidates are in mid stages of development. These candidates still have a long way to go before hitting the market. The company relies highly on collaborators for funding. Any development/regulatory setback would be a negative for the company.  However, Alnylam reported positive data from the ATLAS study in the first quarter which led to regulatory filings for its late-stage pipeline candidate patisiran and the FDA set an action date of Aug 11, 2018. The company along with its partners Sanofi and The Medicines Company, restarted fitusiran's ATLAS phase III study and advanced inclisiran in the ORION-9, -10, and -11 phase III studies, respectively, with results expected for both programs in 2019. Alnylam expects to achieve the profile of three marketed products by the end of 2020.”

  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) released first-quarter results last week, but all eyes were looking forward as the company waits for a potential approval of its hereditary TTR amyloidosis (ATTR) drug, patisiran.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Alnylam Pharmaceuticals (ALNY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights]

    It’s not exactly David vs. Goliath. However, Bellicum Pharmaceuticals (NASDAQ:BLCM) and Alnylam Pharmaceuticals (NASDAQ:ALNY) are definitely in different leagues right now. Both are clinical-stage biotechs, but Bellicum’s market cap is less than $350 million while Alnylam’s market cap is close to $10 billion.

Top 10 Heal Care Stocks To Own Right Now: Prudential Public Limited Company(PUK)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the news headlines that may have effected Accern’s rankings:

    Get Prudential alerts:

    Zacks Investment Research Lowers Prudential (PUK) to Hold (americanbankingnews.com) Financial wellness program popularity rises among employers, up 63 percentage points in two years (markets.financialcontent.com) FY2018 EPS Estimates for Prudential (PUK) Reduced by Jefferies Group (americanbankingnews.com) Jefferies Group Weighs in on Prudential’s FY2020 Earnings (PUK) (americanbankingnews.com) ValuEngine Downgrades Prudential (PUK) to Hold (americanbankingnews.com)

    Shares of PUK stock traded down $0.02 during trading on Tuesday, hitting $51.56. 141,455 shares of the stock traded hands, compared to its average volume of 198,097. The firm has a market cap of $66.49 billion, a PE ratio of 13.79, a PEG ratio of 1.34 and a beta of 1.55. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.03 and a current ratio of 0.03. Prudential has a 52-week low of $44.49 and a 52-week high of $55.36.

  • [By Ethan Ryder]

    Prudential (NYSE: PUK) and Reinsurance Group of America (NYSE:RGA) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

  • [By Ethan Ryder]

    ValuEngine lowered shares of Prudential (NYSE:PUK) from a buy rating to a hold rating in a research note issued to investors on Wednesday morning.

    Several other analysts have also recently issued reports on the stock. Zacks Investment Research upgraded shares of Prudential from a hold rating to a buy rating and set a $57.00 target price on the stock in a research note on Tuesday, March 27th. Berenberg Bank cut shares of Prudential from a hold rating to a sell rating in a research note on Thursday, March 29th. Finally, Citigroup cut shares of Prudential from a buy rating to a neutral rating in a research note on Wednesday, April 25th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. The stock currently has an average rating of Hold and an average price target of $57.00.

Top 5 Stocks To Watch Right Now

For years, Republicans have been saying that Social Security has been going bust. True, the system will run short of money to pay full benefits, but that won’t happen soon, and it’s based on the premise that nothing can be done to fund the program.

Yet instead of raising the income limits on Social Security taxes — a relatively easy thing to do — the GOP approach to “saving” Social Security is to carve it up, cut benefits and privatize it. That’s not a viable solution for the millions of Americans who are coming up short on retirement funding.

The latest GOP proposal, which flies in the face of Donald Trump’s campaign promises to protect the program, is more of the same. Cut benefits and harm retirees who depend upon it.

Although arguably the GOP plan could put more money back into the Social Security Trust Fund, it does so at an extreme cost. And since there are other funding alternatives, it’s a cruel way to save the program.

Shutterstock

Top 5 Stocks To Watch Right Now: magicJack VocalTec Ltd(CALL)

Advisors’ Opinion:

  • [By Peter Graham]

    Any smidgen of magic left in magicJack VocalTec (CALL) is vanishing quicker than street magician David Blaine can make a new quarter disappear.

    Now the former star of annoying, late-night TV commercials only wishes it could make its melting core business model reappear.

  • [By Monica Gerson]

    magicJack VocalTec Ltd (NASDAQ: CALL) is projected to post its quarterly earnings at $0.30 per share on revenue of $25.00 million.

    Rentech, Inc. (NASDAQ: RTK) is estimated to post a quarterly loss at $0.08 per share on revenue of $81.02 million.

  • [By Peter Graham]

    Any smidgen of magic left in magicJack VocalTec (CALL) is vanishing quicker than street magician David Blaine can make a new quarter disappear.

    Now the former star of annoying, late-night TV commercials only wishes it could make its melting core business model reappear.

Top 5 Stocks To Watch Right Now: Alaska Air Group, Inc.(ALK)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    Last year, a potential solution appeared when Alaska Air (NYSE:ALK) acquired Virgin America, which is the only other commercial airline at Love Field, whereas Alaska Airlines flies to nearby Dallas-Fort Worth International Airport (DFW). It seemed plausible that Alaska would consolidate its Dallas-area operations at DFW, the region’s main airport.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Friday was Alaska Air Group, Inc. (NYSE: ALK) which rose about 6% to $64.10. The stocks 52-week range is $57.60 to $95.75. Volume was over 4 million compared to the daily average volume of 2.7 million.

  • [By Adam Levine-Weinberg]

    While Southwest Airlines achieved the best score overall, Alaska Air (NYSE:ALK) received top marks among traditional carriers. This was its 10th consecutive victory in the traditional carrier segment.

  • [By Ben Levisohn]

    Airlines like United Continental (UAL), Alaska Air Group (ALK) and JetBlue Airways (JBLU) have been so cheap for so long now, that making an argument for big gains based solely on valuation seems remarkably foolish. Thankfully, it’s not the only argument that Barclays analyst Brandon Oglenski make as they initiated the sector with a Positive rating, while calling United Continental the “most compelling stock” in the airlines sector. They explain why:

Top 5 Stocks To Watch Right Now: Westell Technologies, Inc.(WSTL)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap high-performance wireless infrastructure solutions stock Westell Technologies (NASDAQ: WSTL) as a buy for our short-term portfolio:

Top 5 Stocks To Watch Right Now: (SHF)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    In March 2012, Schiff Nutrition International Inc. (NYSE: SHF) acquired the company for $150 million in cash.

    The product is still on the market today, found at most local drug stores. It is advertised now, however, as a nutritional supplement that does not, if taken alone, ward off viruses.

Top 5 Stocks To Watch Right Now: Akamai Technologies, Inc.(AKAM)

Advisors’ Opinion:

  • [By Anders Bylund]

    Shares of Akamai Technologies (NASDAQ:AKAM) rose 26.7% in 2016, according to data from S&P Global Market Intelligence. Coming off a drastic 28% drop in the last 10 weeks of 2015, the content distribution specialist bounced back quickly.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Akamai Technologies, Inc. (NASDAQ: AKAM) which rose about 7% to $74.89. The stocks 52-week range is $44.65 to $75.00. Volume was roughly 4 million compared to the daily average volume of 2.3 million.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Akamai Technologies, Inc. (NASDAQ: AKAM) which rose about 14% to $65.67. The stocks 52-week range is $44.65 to $71.64. Volume was 14.5 million compared to its average volume of 2 million.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Akamai Technologies, Inc. (NASDAQ: AKAM) which traded down over 14% at $45.51. The stocks 52-week range is $45.41 to $71.64. Volume wasover 14 million versus the daily average of 2.6 million shares.

Best Clean Energy Stocks To Buy Right Now

Related KOL Coal Companies Lobby For Clean Energy Subsidies Silver Shines Among 2016's Best ETFs

The VanEck Vectors Coal ETF (NYSE: KOL) was one of last year's best-performing non-leveraged exchange-traded funds for a simple reason: Of the two nominees for the U.S. presidency, one was vocal in her disdain for the coal industry while one vowed to restore the industry's lost jobs.

President Donald Trump, obviously, was the candidate that promised to restore coal country's lost glory and KOL responded. The ETF is doing so again this year with a year-to-date gain of almost 18 percent. That means KOL has nearly doubled in value over the past year. Still, there are ample indications that Trump's promises to coal miners will be hard to keep.

Best Clean Energy Stocks To Buy Right Now: Emerald Health Therapeutics, Inc. (TBQBF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Emerald Health Therapeutics Inc (OTC: TBQBF) raised C$13.8 million ($10.5 million) under a bought deal financing.

    “The money will be primarily used for facility expansion."

    The Green Solution received a $7.5 million loan facility from iAnthus Capital Holdings Inc (OTC: ITHUF).

Best Clean Energy Stocks To Buy Right Now: Williams Partners L.P.(WPZ)

Advisors’ Opinion:

  • [By Ben Levisohn]

    In a release after the close on Monday, Williams and Williams Partners (WPZ) made several announcements, including: 1) outlining managements plan to financially reposition and simplify the franchises GP/LP structure in an ~$11.4 billion transaction (not subject to any additional approvals), 2) adjustments to Williams and Williams Partners’ dividend and distribution payouts, 3) initiating a ~$2+ billion William equity raise to fund a further Williams investment in Williams Partners, 4) noted other potential upcoming changes, including the sale of ~$2 billion in non-core assets in 2017, and 5) provided several forms of updated 2017 guidance…

Best Clean Energy Stocks To Buy Right Now: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Travis Hoium]

    The ups and downs of revenue and earnings atInteractive Brokers Group, Inc. (NASDAQ:IBKR)struck again in the first quarter of 2017. Trading and market making were down versus a year before,but the company still reported a profit and is making long-term adjustments that could make the business more profitable for investors.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than

Best Clean Energy Stocks To Buy Right Now: Akamai Technologies, Inc.(AKAM)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Akamai Technologies, Inc. (NASDAQ: AKAM) which rose about 14% to $65.67. The stocks 52-week range is $44.65 to $71.64. Volume was 14.5 million compared to its average volume of 2 million.

  • [By Anders Bylund]

    Shares of Akamai Technologies (NASDAQ:AKAM) rose 26.7% in 2016, according to data from S&P Global Market Intelligence. Coming off a drastic 28% drop in the last 10 weeks of 2015, the content distribution specialist bounced back quickly.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Akamai Technologies, Inc. (NASDAQ: AKAM) which rose about 7% to $74.89. The stocks 52-week range is $44.65 to $75.00. Volume was roughly 4 million compared to the daily average volume of 2.3 million.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Akamai Technologies, Inc. (NASDAQ: AKAM) which traded down over 14% at $45.51. The stocks 52-week range is $45.41 to $71.64. Volume wasover 14 million versus the daily average of 2.6 million shares.

  • [By Paul Ausick]

    Akamai Technologies Inc. (NASDAQ: AKAM) dropped about 15% Wednesday to post a new 52-week low of $45.45 after closing at $53.28 on Tuesday. The stock’s 52-week high is $71.64. Volume of about 13 million was roughly 5 times the daily average. The company reported decent results, but soft guidance for the current quarter sank the stock in Wednesday’s session.